%0
Generic
%T
Outcomes in Patients with High-Risk Features after Fixed-Duration Ibrutinib plus Venetoclax: Phase II CAPTIVATE Study in First-Line Chronic Lymphocytic Leukemia
%A Allan, John N.
%A Flinn, Ian W.
%A Siddiqi, Tanya
%A Ghia, Paolo
%A Tam, Constantine S.
%A Kipps, Thomas J.
%A Barr, Paul M.
%A Elinder Camburn, Anna
%A Tedeschi, Alessandra
%A Badoux, Xavier C.
%A Jacobs, Ryan
%A Kuss, Bryone J.
%A Trentin, Livio
%A Zhou, Cathy
%A Szoke, Anita
%A Abbazio, Christopher
%A Wierda, William G.
%I American Association for Cancer Research (AACR)
%@ 1078-0432
%@ 1557-3265
%D 2023
%C American Association for Cancer Research (AACR)